⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MXCT News
MaxCyte, Inc. Common Stock
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
MXCT
MaxCyte Announces Planned CFO Transition in 2026
globenewswire.com
MXCT
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
globenewswire.com
MXCT
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
globenewswire.com
MXCT
MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
globenewswire.com
MXCT
MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
globenewswire.com
MXCT